Fetal Aneuploidy clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy
open to eligible females ages 18 years and up
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
Our lead scientists for Fetal Aneuploidy research studies include Andrew Hull, MD.